Giant cell myocarditis is a rare cause of cardiogenic shock requiring a high index of suspicion, rapid immunosuppressive therapy, and mechanical circulatory support. We present the case of a patient with giant cell myocarditis who underwent a successful bridge with four different types of mechanical circulatory support devices to heart transplantation.
JACC Editor-in-Chief Julia Grapsa, MD, PhD, FACCCME Editor Nadeen N. Faza, MD, FACC
AuthorsYevgeniy Brailovsky, DO, MSCAmirali Masoumi, MDRachel Bijou, MDEstefania Oliveros, MD, MSCGabriel Sayer, MDKoji Takeda, MD, PHDNir Uriel, MD, MSC
Important Dates
Date of Release: March 2, 2022Term of Approval/Date of CME/MOC/ECME Expiration: March 1, 2023